No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
227 |
4. Check minimum number of eventsNone |
227 |
5. Include endpointsNone |
227 |
6. Filter based on genotype QC (FinnGen only) |
221 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of penis, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 221 | - | 221 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 67.64 | - | 67.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 227
- Matched controls
- 2270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
144.8
123
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
108.2
95
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
1196.8
86.6
79
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
82.4
74
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
47.8
81.2
49
13
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
80.0
72
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
68.2
62
*
116
Kela drug reimbursment
Prostate cancer
+∞
60.1
55
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
56.7
52
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
55.5
51
*
JN4AD
NOMESCO Finland
Body CT examination
12.6
51.4
57
59
KGB00
NOMESCO Finland
Biopsy of penis
318.6
51.3
50
*
KGH10
NOMESCO Finland
Operation for phimosis
12.1
47.9
54
57
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
46.5
43
*
130
Kela drug reimbursment
Malignant tumour
+∞
45.3
42
*
JN4BD
NOMESCO Finland
Extensive body CT
11.7
44.5
51
55
N48.1
ICD-10 Finland
Balanoposthitis
15.4
43.8
41
32
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
+∞
43.1
40
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
42.0
39
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
40.9
38
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.0
40.7
58
83
H02AB02
ATC
dexamethasone; systemic
64.0
36.9
42
8
UKC02
NOMESCO Finland
Cystoscopy
5.8
36.4
95
250
WX402
NOMESCO Finland
General anaesthesia
6.3
36.0
78
173
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
9.2
35.4
48
64
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
35.3
33
*
L02BB03
ATC
bicalutamide; oral
+∞
34.2
32
*
Z51.5
ICD-10 Finland
Palliative care
10.9
29.6
34
36
WF002
NOMESCO Finland
Radical radiotherapy
+∞
28.8
27
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
27.7
26
*
Y77
ICPC
Malignant neoplasm prostate
+∞
26.6
25
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.3
26.3
34
42
ZZA00
NOMESCO Finland
Split skin graft
11.7
25.9
28
27
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
24.4
23
*
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
24.4
23
*
KGD96
NOMESCO Finland
Other partial excision of penis
+∞
23.3
22
*
B01AB10
ATC
tinzaparin; parenteral
7.8
23.2
35
52
XKD00
NOMESCO Finland
Uroflowmetry
4.0
22.0
90
320
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
242.4
22.0
22
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
7.6
21.5
33
50
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
21.3
86
302
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.6
21.2
46
99
A04AA02
ATC
granisetron; systemic, transdermal
+∞
21.2
20
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.0
20.9
81
276
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
20.1
19
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.1
19
*
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
20.1
19
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
6.4
19.8
36
65
WX408
NOMESCO Finland
General anesthesy, balanced
3.9
19.5
79
276
WF049
NOMESCO Finland
Radiotherapy of metastasis
206.3
18.8
19
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.9
17
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
17.9
17
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
17.9
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.9
17
*
WZC30
NOMESCO Finland
Teaching
4.2
16.4
52
151
N02AA05
ATC
oxycodone; systemic
3.9
16.3
57
178
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.6
16.0
33
67
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
15.9
100
452
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
171.3
15.7
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.0
15.6
37
85
KGC10
NOMESCO Finland
Total amputation of penis
+∞
14.7
14
*
TKD00
NOMESCO Finland
Dilatation of urethra
57.1
14.0
16
*
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
80.1
13.7
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.7
13
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
13.7
13
*
A04AA01
ATC
ondansetron; systemic, rectal
16.7
12.9
20
13
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
18.7
12.8
19
11
KDH10
NOMESCO Finland
Meatoplasty of urethra
74.1
12.7
14
*
WX240
NOMESCO Finland
Penis blockade
26.1
12.7
17
7
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
12.6
12
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
12.6
12
*
J01EA01
ATC
trimethoprim; systemic
3.6
12.5
47
152
R33
ICD-10 Finland
Retention of urine
3.5
12.3
49
165
J01MA02
ATC
ciprofloxacin; systemic
2.7
12.2
112
601
ZX120
NOMESCO Finland
Intravenous
4.7
12.2
30
71
B01AB05
ATC
enoxaparin; parenteral
2.8
11.8
80
366
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.6
11
*
L02BB04
ATC
enzalutamide; oral
+∞
11.6
11
*
L03AA02
ATC
filgrastim; parenteral
126.1
11.5
12
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
126.1
11.5
12
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
126.1
11.5
12
*
KGD10
NOMESCO Finland
Destruction of lesion of penis
37.1
11.4
14
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
26.6
11.3
15
6
WX320
NOMESCO Finland
Spinalanesthesy
2.8
10.5
71
322
L03AA13
ATC
pegfilgrastim; parenteral
115.1
10.5
11
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.5
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.5
10
*
J01DB01
ATC
cefalexin; oral
3.2
10.3
190
1394
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.4
9.9
13
5
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
9.9
37
119
JN4CD
NOMESCO Finland
Very extensive body CT
16.0
9.7
15
10
TKC20
NOMESCO Finland
Catheterisation of bladder
3.8
9.6
32
95
KCD02
NOMESCO Finland
Transurethral resection of bladder
31.5
9.5
12
*
N48.9
ICD-10 Finland
Disorder of penis, unspecified
31.5
9.5
12
*
C60
ICD-10 Finland
Malignant neoplasm of penis
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
L02BX02
ATC
degarelix; parenteral
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
R31
ICD-10 Finland
Unspecified haematuria
3.0
9.3
46
175
G04BE03
ATC
sildenafil; oral
38.3
9.1
11
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
9.0
38
132
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.1
8.9
21
32
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
93.4
8.5
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.4
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.4
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.4
8
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
8.4
8
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.4
8
*
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
9.5
8.2
16
18
QBA10
NOMESCO Finland
Incision of skin of trunk
34.7
8.1
10
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
9.9
7.9
15
16
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
46.6
7.8
9
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
8.5
7.7
16
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
7.7
40
156
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
7.6
25
73
N48.5
ICD-10 Finland
Ulcer of penis
26.0
7.6
10
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
26.0
7.6
10
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.1
7.5
16
21
N48.8
ICD-10 Finland
Other specified disorders of penis
14.0
7.5
12
9
ZX090
NOMESCO Finland
Other technic of radiotherapy
82.7
7.5
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.9
7.4
14
15
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
L02BX03
ATC
abiraterone; oral
+∞
7.3
7
*
XJH00
NOMESCO Finland
Transanal ultrasonography
3.3
7.2
28
92
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.2
7.2
14
16
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
7.1
38
150
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
7.0
70
372
J01MA12
ATC
levofloxacin; systemic
2.5
7.0
53
250
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
6.9
40
165
ZXC96
NOMESCO Finland
Robot assisted procedure
41.3
6.8
8
*
ZX112
NOMESCO Finland
Subcutaneous
41.3
6.8
8
*
Z3231
NOMESCO Finland
Registered nurse
2.3
6.8
65
340
N30.0
ICD-10 Finland
Acute cystitis
3.7
6.8
22
64
M05BX04
ATC
denosumab; parenteral
8.2
6.7
14
18
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
6.6
39
162
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
6.5
30
109
KC1GB
NOMESCO Finland
Cystography with X-ray
71.8
6.5
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
71.8
6.5
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
6.4
56
280
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.8
6.4
17
31
N02BE01
ATC
paracetamol; systemic, rectal
2.6
6.3
195
1584
Y78
ICPC
Malign neopl male genital other
+∞
6.3
6
*
L02AE03
ATC
goserelin; implant
+∞
6.3
6
*
L02AE04
ATC
triptorelin; parenteral
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
KGW96
NOMESCO Finland
Other operation on penis
+∞
6.3
6
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
KGA10
NOMESCO Finland
Incision of prepuce
+∞
6.3
6
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
6.3
6
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
27.5
6.3
8
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.0
6.1
12
14
WW500
NOMESCO Finland
Blood transfusion
9.0
6.1
12
14
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
6.0
24
80
ZXE00
NOMESCO Finland
One hour or less
2.0
6.0
84
506
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
140
656
3.96
22.94
3.8
2.3
—
—
—
0
0
166
940
3.85
19.05
6.6
3.6
18.29
580.50
e6/l
—
7
16
82
344
3.17
14.61
3.3
2.1
—
—
—
0
0
65
275
2.91
11.03
1.9
1.8
—
—
—
0
0
171
1173
2.86
10.82
12.9
5.3
82.41
74.97
u/l
1.59
160
1079
26
62
4.61
10.41
2.2
1.9
2.79
2.12
ug/l
0.11
19
55
103
570
2.48
10.04
5.2
2.8
—
—
—
0
0
121
723
2.44
9.93
10.4
5.9
1.19
1.20
mmol/l
0.98
100
618
114
668
2.42
9.71
8.0
3.6
34.13
35.49
g/l
1.83
106
608
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
56
4.46
8.95
2.4
2.4
0.26
0.34
u/ml
0.90
13
28
131
850
2.28
8.41
14.7
19.4
1.33
1.41
inr
0.44
38
235
81
431
2.37
8.32
4.3
2.6
0.39
0.35
e6/l
0.10
66
324
125
812
2.20
7.80
16.1
6.0
4.34
4.46
e9/l
0.20
113
714
108
666
2.19
7.64
9.8
5.5
1.19
1.20
mmol/l
1.29
100
591
41
163
2.85
7.62
4.4
3.3
—
—
—
0
0
54
257
2.44
6.98
4.2
2.7
0.81
0.62
e6/l
0.29
35
147
48
232
2.36
5.94
7.8
5.8
105.58
104.55
mmol/l
1.22
48
232
43
200
2.42
5.79
1.7
1.8
—
—
—
0
0
53
273
2.23
5.64
4.0
2.5
1.38
1.04
e6/l
0.38
35
163
45
217
2.34
5.58
4.1
2.4
18.48
24.87
%
2.72
38
184
105
701
1.93
5.48
6.1
4.4
0.00
0.00
estimate
-0.00
22
117
24
90
2.86
4.93
7.9
8.9
24.00
24.58
mmol/l
0.52
24
85
105
719
1.86
4.93
4.4
3.2
0.00
0.00
estimate
-0.00
21
107
20
68
3.13
4.85
2.0
1.6
—
—
—
0
0
26
103
2.72
4.83
1.8
1.6
—
—
—
0
0
103
707
1.84
4.75
4.5
3.2
0.00
0.01
estimate
0.50
23
123
40
199
2.23
4.58
1.8
1.8
—
—
—
0
0
85
565
1.81
4.26
4.7
3.4
—
—
—
0
0
7
7
10.27
4.03
1.1
1.1
—
—
—
0
0
12
27
4.63
3.99
1.3
1.4
—
—
—
0
0
17
60
2.98
3.88
1.9
1.4
—
—
—
0
0
6
5
12.27
3.78
1.2
1.0
—
—
—
0
0
6
5
12.27
3.78
1.2
1.0
—
—
—
0
0
12
29
4.31
3.76
1.8
1.5
—
—
—
0
0
71
462
1.78
3.74
7.8
2.0
2.35
2.33
mmol/l
0.69
64
375
10
20
5.18
3.73
1.1
1.4
—
—
—
0
0
186
1591
1.94
3.63
29.4
13.3
32.91
27.32
mg/l
1.18
171
1223
10
21
4.93
3.60
1.9
1.4
—
—
—
0
0
10
21
4.93
3.60
1.1
1.4
—
—
—
0
0
8
14
5.88
3.37
1.6
1.0
—
—
—
0
0
8
14
5.88
3.37
1.9
1.6
—
—
—
0
0
8
14
5.88
3.37
1.6
1.0
—
—
—
0
0
8
14
5.88
3.37
1.6
1.0
—
—
—
0
0
8
14
5.88
3.37
1.6
1.0
—
—
—
0
0
8
14
5.88
3.37
1.6
1.0
—
—
—
0
0
8
14
5.88
3.37
1.6
1.0
—
—
—
0
0
10
23
4.50
3.35
1.4
1.3
—
—
—
0
0
11
28
4.07
3.33
1.8
1.5
—
—
—
0
0
55
343
1.80
3.31
2.4
1.8
1294.21
1196.51
nmol/l
0.23
44
270
13
43
3.15
3.31
1.9
1.4
—
—
—
0
0
7
11
6.52
3.21
1.7
1.4
9.84
11.72
ug/l
—
7
11
8
16
5.14
3.08
1.3
1.2
—
—
—
0
0
21
95
2.33
3.00
1.7
1.5
—
—
—
0
0
5
5
10.18
2.99
1.2
1.0
—
—
—
0
0
5
5
10.18
2.99
1.2
1.0
—
—
—
0
0
5
5
10.18
2.99
1.0
1.2
7.80
86.20
u/l
—
5
5
5
5
10.18
2.99
1.0
1.2
52.80
204.40
u/l
—
5
5
8
17
4.84
2.94
1.9
1.2
—
—
—
0
0
10
27
3.82
2.91
1.5
1.2
—
—
—
0
0
70
485
1.64
2.85
3.3
2.8
29.47
36.54
u/l
1.41
64
454
6
10
6.13
2.71
1.7
1.3
—
—
—
0
0
7
15
4.78
2.61
2.4
1.5
163.77
2.59
u/ml
—
7
15
12
44
2.82
2.59
1.2
1.2
—
—
—
0
0
173
1503
1.63
2.55
27.3
12.0
75.93
76.63
ml/min/173m2
0.13
152
1229
60
411
1.63
2.52
2.4
2.1
3.34
2.90
mg/l
0.60
53
341
12
45
2.76
2.49
3.3
1.3
—
1.17
—
0
6
155
1317
1.56
2.47
31.5
15.3
15.35
15.14
%
0.18
155
1288
36
217
1.78
2.41
7.7
6.7
0.11
1.09
mmol/l
0.60
31
166
136
1129
1.51
2.37
4.6
3.7
17.40
11.56
mm/h
2.82
124
1030
10
37
2.78
2.10
1.2
1.6
—
—
—
0
0
43
285
1.63
2.05
6.8
2.0
2.50
2.43
mmol/l
2.26
37
237
49
336
1.58
2.03
4.0
3.6
1.02
1.02
kg/l
0.19
16
50
150
1295
1.47
1.98
7.5
3.9
28.57
2.01
ug/l
0.65
136
1145
5
11
4.62
1.95
1.8
1.3
—
—
—
0
0
189
1714
1.61
1.95
31.6
16.6
4.04
4.04
mmol/l
0.14
184
1657
9
34
2.71
1.88
1.0
1.2
—
—
—
0
0
9
34
2.71
1.88
1.0
1.2
—
—
—
0
0
22
123
1.87
1.88
4.2
1.8
68.11
67.21
g/l
0.21
22
107
57
418
1.49
1.74
1.7
1.5
16.68
18.38
nmol/l
0.54
51
355
10
40
2.57
1.69
1.6
1.5
—
0.08
—
0
12
6
19
3.21
1.67
1.8
1.6
—
—
—
0
0
6
19
3.21
1.67
1.8
1.6
—
—
—
0
0
86
691
1.39
1.59
2.2
2.0
90.08
91.39
pmol/l
0.08
51
401
6
20
3.05
1.59
1.0
1.5
—
—
—
0
0
188
1728
1.51
1.55
34.1
15.7
97.38
90.19
umol/l
0.87
188
1728
7
28
2.55
1.46
2.3
2.5
105.43
105.25
mmol/l
—
7
28
6
22
2.77
1.44
5.3
5.7
10.60
11.04
mg/l
—
6
22
5
17
2.98
1.36
1.6
1.6
—
—
—
0
0
21
129
1.69
1.35
8.3
3.6
0.67
1.83
mmol/l
0.77
15
96
6
24
2.54
1.31
1.5
1.0
—
—
—
0
0
75
607
1.35
1.29
3.4
3.2
5547.88
1708.39
ng/l
1.05
65
521
5
18
2.82
1.29
2.2
1.9
—
—
—
0
0
95
797
1.33
1.29
2.1
2.4
—
—
—
0
0
13
70
1.91
1.26
2.1
4.2
—
—
—
0
0
71
572
1.35
1.26
4.0
2.6
219.38
183.96
ug/l
0.36
64
515
5
19
2.67
1.22
3.0
2.5
61.00
58.74
%
—
5
19
12
64
1.92
1.20
1.1
1.8
—
—
—
0
0
14
79
1.82
1.20
1.2
1.3
1131.51
237.94
u/ml
0.49
14
72
191
1789
1.43
1.15
41.6
19.4
38.58
41.11
%
3.80
178
1640
191
1790
1.42
1.13
41.5
19.3
232.97
228.57
e9/l
0.38
186
1727
18
112
1.66
1.12
1.8
2.1
27.17
35.23
u/l
0.58
12
93
191
1791
1.42
1.12
41.5
19.3
4.34
4.61
e12/l
6.72
186
1723
184
1716
1.38
1.10
15.7
8.7
26.93
29.20
u/l
0.78
174
1634
51
400
1.35
1.07
5.1
3.4
0.00
0.03
estimate
0.50
19
107
117
1030
1.28
1.06
3.6
3.1
67.90
54.06
u/l
0.87
110
954
7
34
2.09
1.04
6.9
1.2
20.73
13.91
u/l
—
7
29
7
35
2.03
1.01
2.0
1.3
—
—
—
0
0
11
61
1.84
1.00
2.9
2.2
38.93
37.69
u/l
0.07
11
54
17
108
1.62
1.00
1.4
1.4
—
—
—
0
0
7
36
1.97
0.98
3.7
3.5
62.29
22.40
mg/l
—
7
30
13
204
0.62
0.91
2.0
2.8
10.03
9.55
ug/l
—
8
177
8
42
1.94
0.89
1.8
1.2
—
—
—
0
0
6
30
2.03
0.87
2.5
1.8
—
—
—
0
0
13
197
0.64
0.79
1.1
1.2
0.90
9.37
u/ml
—
5
75
12
75
1.63
0.76
1.2
1.8
—
—
—
0
0
7
41
1.73
0.70
1.9
1.3
—
—
—
0
0
85
750
1.21
0.69
4.9
4.1
39.60
52.58
ng/l
0.69
72
569
7
43
1.65
0.67
1.7
1.5
—
—
—
0
0
7
43
1.65
0.67
1.0
1.8
—
—
—
0
0
44
363
1.26
0.66
3.7
3.8
311.47
490.26
ng/l
0.32
34
301
29
226
1.32
0.65
5.1
4.9
29.43
30.68
%
0.28
21
154
39
317
1.28
0.65
1.4
1.7
1.23
1.29
mg/l
0.08
33
243
57
487
1.23
0.63
3.6
2.6
13424.12
8500.54
umol/l
0.18
50
426
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
6
36
1.68
0.57
4.0
1.3
0.00
0.00
g/l
—
6
31
18
230
0.76
0.46
6.8
7.8
—
—
—
0
0
7
50
1.41
0.45
3.6
1.3
9.44
10.75
g/l
—
7
40
158
1651
0.86
0.45
4.8
5.3
2.55
2.57
mmol/l
0.09
140
1506
0
17
0.00
0.41
0.0
3.4
—
—
—
0
0
6
42
1.44
0.36
4.0
1.4
0.00
0.00
g/l
—
6
37
6
46
1.31
0.33
4.0
1.2
36.85
37.56
g/l
—
6
36
22
183
1.22
0.33
5.0
3.3
6.14
5.71
kpa
1.11
22
175
7
56
1.26
0.29
3.6
1.4
3.16
2.97
g/l
—
7
46
109
1036
1.10
0.27
6.2
3.7
20.64
24.30
%
1.48
57
479
77
720
1.11
0.26
3.5
2.6
1.07
0.78
ug/l
0.55
49
474
0
11
0.00
0.21
0.0
10.7
—
30.60
—
0
5
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
56
522
1.10
0.20
2.7
2.1
70.97
75.40
nmol/l
0.72
47
453
0
14
0.00
0.20
0.0
1.0
—
29.70
—
0
9
163
1590
1.09
0.20
4.7
4.8
6.26
6.17
mmol/l
0.43
146
1420
7
59
1.19
0.18
3.6
1.4
8.03
7.51
g/l
—
7
49
7
59
1.19
0.18
3.6
1.4
—
—
—
0
0
100
1037
0.94
0.16
3.1
2.9
14.34
15.09
pmol/l
2.47
89
911
14
121
1.17
0.15
2.1
1.9
—
—
—
0
0
153
1560
0.94
0.13
4.5
4.2
1.51
1.33
mmol/l
2.16
133
1407
11
94
1.18
0.13
3.8
2.3
1.10
1.22
%
0.11
11
94
158
1609
0.94
0.13
4.9
4.8
4.40
4.33
mmol/l
0.31
138
1469
12
136
0.88
0.11
1.6
1.2
—
—
—
0
0
5
47
1.07
0.09
1.2
1.0
—
—
—
0
0
158
1601
0.96
0.08
4.4
4.7
1.24
1.31
mmol/l
1.73
136
1452
10
91
1.10
0.04
3.5
2.2
0.70
0.62
%
—
10
91
40
410
0.97
0.03
2.0
1.8
1.66
1.41
mmol/l
0.97
31
337
61
620
0.98
0.02
5.0
3.9
20.67
10.56
mg/mmol
0.72
46
421
16
154
1.04
0.00
5.1
2.7
5.69
4.59
kpa
0.59
16
145
138
1381
1.00
0.00
3.6
3.7
2.01
2.01
mu/l
0.01
118
1222
154
1538
1.00
0.00
6.6
6.6
41.79
41.21
mmol/mol
0.30
133
1406
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
13.63
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PENIS_WIDE – Malignant neoplasm of penis, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).